ALLO Allogene Therapeutics Inc

2,757

$3.17

$0.24

(7.04%)

Today

Watchers	2,757
52-Wk Low	$3.08
52-Wk High	$12.21

Market Cap	$531.37M
Volume (M)	2.86M
52-Wk High	$12.21
52-Wk Low	$3.08

Fundamentals

Allogene Therapeutics participates in a conference call with JPMorganThe Fly • 5 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Share to Feed

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T Platform at the Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobe Newswire • 5 days ago

Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T Cells Demonstration of Dagger Technology to Engineer CAR T cells to Selectively Eliminate...

Allogene Therapeutics (ALLO, $3.51) price may climb as it broke lower Bollinger Band on Sep 25, 2023Tickeron - Stocks • 6 days ago

This price move could be a signal that ALLO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Allogene Therapeutics (NASDAQ:ALLO) Stock Price Down 3.8% on Analyst DowngradeZolmax • 6 days ago

Allogene Therapeutics, Inc. (NASDAQ:ALLO Get Free Report) shares traded down 3.8% on Monday after JPMorgan Chase Co. lowered their price target on the stock from $11.00 to $9.00...

Allogene Therapeutics price target lowered to $9 from $11 at JPMorganThe Fly • 6 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Allogene Therapeutics (NASDAQ:ALLO) Trading Down 3.8% Following Analyst DowngradeTicker Report • 7 days ago

Allogene Therapeutics, Inc. (NASDAQ:ALLO Get Free Report)s share price dropped 3.8% during trading on Monday after JPMorgan Chase Co. lowered their price target on the stock from...

Allogene Therapeutics (ALLO, $3.65) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 22, 2023Tickeron - Stocks • 9 days ago

This is a Bearish indicator signaling ALLO's price could decline from here. Traders may explore shorting the stock or put options...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Holdings Increased by Nordea Investment Management ABZolmax • 10 days ago

Nordea Investment Management AB increased its position in Allogene Therapeutics, Inc. (NASDAQ:ALLO Free Report) by 20.1% in the 2nd quarter, according to the company in its most recent Form...

Allogene Therapeutics (ALLO, $4.11) price may drop as it broke higher Bollinger Band on Sep 06, 2023Tickeron - Stocks • 25 days ago

This price move could be a signal that ALLO may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Citigroup Inc. Grows Stock Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)Zolmax • 27 days ago

Citigroup Inc. raised its holdings in Allogene Therapeutics, Inc. (NASDAQ:ALLO Free Report) by 61.3% in the 1st quarter, according to its most recent 13F filing with the Securities and...